CYCCP
Price
$5.26
Change
-$0.23 (-4.19%)
Updated
Jun 30, 10:30 AM (EDT)
Capitalization
31.65
PROK
Price
$0.59
Change
-$0.08 (-11.94%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
86.62M
38 days until earnings call
Interact to see
Advertisement

CYCCP vs PROK

Header iconCYCCP vs PROK Comparison
Open Charts CYCCP vs PROKBanner chart's image
Cyclacel Pharmaceuticals
Price$5.26
Change-$0.23 (-4.19%)
VolumeN/A
Capitalization31.65
ProKidney
Price$0.59
Change-$0.08 (-11.94%)
Volume$6.76K
Capitalization86.62M
CYCCP vs PROK Comparison Chart in %
Loading...
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCCP vs. PROK commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCCP is a Buy and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (CYCCP: $5.49 vs. PROK: $0.67)
Brand notoriety: CYCCP and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCCP: 125% vs. PROK: 1163%
Market capitalization -- CYCCP: $31.65 vs. PROK: $76.69M
CYCCP [@Biotechnology] is valued at $31.65. PROK’s [@Biotechnology] market capitalization is $76.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCCP’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CYCCP’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, CYCCP is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCCP’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • CYCCP’s TA Score: 3 bullish, 5 bearish.
  • PROK’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CYCCP is a better buy in the short-term than PROK.

Price Growth

CYCCP (@Biotechnology) experienced а +3.58% price change this week, while PROK (@Biotechnology) price change was +1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

PROK is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($86.6M) has a higher market cap than CYCCP($31.65). CYCCP YTD gains are higher at: -22.159 vs. PROK (-60.432). CYCCP has higher annual earnings (EBITDA): -12.68M vs. PROK (-160.12M). PROK has more cash in the bank: 328M vs. CYCCP (3.45M). CYCCP has less debt than PROK: CYCCP (9K) vs PROK (3.37M). PROK has higher revenues than CYCCP: PROK (306K) vs CYCCP (14K).
CYCCPPROKCYCCP / PROK
Capitalization31.6586.6M0%
EBITDA-12.68M-160.12M8%
Gain YTD-22.159-60.43237%
P/E RatioN/AN/A-
Revenue14K306K5%
Total Cash3.45M328M1%
Total Debt9K3.37M0%
FUNDAMENTALS RATINGS
CYCCP: Fundamental Ratings
CYCCP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
31

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCCPPROK
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
63%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
64%
MACD
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
72%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
70%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MXROF0.030.01
+20.19%
MAX Resource Corp.
RGNLF8.78N/A
N/A
REGIONAL S A
KAEPF10.43N/A
N/A
Kansai Electric Power Co., Inc. (The)
MGRUF4.23N/A
N/A
Morguard Real Estate Investment Trust
ADCV0.06N/A
N/A
AD Capital U.S., Inc.

CYCCP and

Correlation & Price change

A.I.dvisor tells us that CYCCP and ARVN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCCP and ARVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCCP
1D Price
Change %
CYCCP100%
+0.73%
ARVN - CYCCP
29%
Poorly correlated
-3.14%
MLEC - CYCCP
23%
Poorly correlated
-7.49%
PROK - CYCCP
22%
Poorly correlated
-7.50%
LYEL - CYCCP
22%
Poorly correlated
-1.97%
GMAB - CYCCP
22%
Poorly correlated
-1.11%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-7.50%
RXRX - PROK
47%
Loosely correlated
-6.85%
IMNM - PROK
44%
Loosely correlated
-0.23%
NAUT - PROK
43%
Loosely correlated
-12.57%
ARCT - PROK
42%
Loosely correlated
-7.49%
DNLI - PROK
42%
Loosely correlated
-2.69%
More